Actively Recruiting

Phase Not Applicable
Age: 6Years - 60Years
All Genders
NCT06708143

Temporal Interference for Drug Resistant Epilepsy

Led by Xuanwu Hospital, Beijing · Updated on 2024-11-27

30

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60.

CONDITIONS

Official Title

Temporal Interference for Drug Resistant Epilepsy

Who Can Participate

Age: 6Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants are between the ages of 6 and 60 years
  • Patients must be clinically evaluated as having drug resistant epilepsy
  • Persistence of disabling seizures at least 2 times per month or greater
  • Informed consent signed
Not Eligible

You will not qualify if you...

  • Psychogenic non-epileptic seizures within 12 months
  • Presence of implanted electrical stimulation medical device anywhere in the body or metallic implants in the head (vagal nerve stimulators allowed if stable for 3 months)
  • Risk factors for intraoperative or postoperative bleeding or need for chronic anticoagulation or antiplatelet medications
  • IQ less than 55 or severe cognitive dysfunction preventing study completion
  • Diagnosed progressive neurological disorder including progressive Rasmussen's encephalitis
  • Severe neuropsychiatric disorder such as dementia, major depression with recent hospitalization or suicidal tendencies, schizophrenia, or neurodegenerative disorders
  • Serious physical disorders, internal diseases, or severe liver or kidney abnormalities
  • Pregnant or planning pregnancy within 2 years
  • Participation in another clinical study within 3 months
  • Not suitable for enrollment as assessed by the multidisciplinary team of the center

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, China, 100053

Actively Recruiting

Loading map...

Research Team

L

Liankun Ren, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Temporal Interference for Drug Resistant Epilepsy | DecenTrialz